Network Pharmacology, Molecular Docking and Dynamics-Based Strategy to Explore the Potential Mechanism of Melatonin Against Thymoma
Ahi Evran Medical Journal · 29.04.2026 · 10 (1) · 120-132
DOI: 10.46332/aemj.1666706 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ahi Evran Medical Journal, online erschienen am 29.04.2026. Verfasst von Emel Akbaba und 1 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben.
Abstract (Originalsprache)
Purpose
Thymic epithelial tumors, although rare neoplasms, are the most common tumors of the anterior mediastinum. They are generally treated with surgery; however, they may also require chemotherapy. Melatonin, known for regulating circadian rhythms, has demonstrated anti-cancer properties However, its effects on thymic epithelial tumors have not yet been investigated.Materials and Methods: Melatonin and thymoma-related proteins (2170 genes) were screened from various databases. Then, protein-protein interaction network of the intersected genes (316 genes) was constructed using STRING database. Cytoscape was utilized to determine hub genes .
Results
KEGG analysis revealed the associated pathways as PI3K-AKT, MAPK, HIF-1, and FOXO. Molecular docking and dy-namics simulations revealed high conformational stability between melatonin and hub genes, notably ESR1 (ER-alpha) and FOS. ESR1 exhibited the lowest MMPBSA binding enthalpy (-100.36 kJ/mol from 100-ns MD simulations), which is distinct from the initial docking scores. Although TP53 showed the lowest docking binding free energy (-11.49 kcal/mol), ESR1 demonstrated superior conformational stability and enthalpic favorability throughout the MD trajectory, suggesting a critical role in modulating estrogen receptor-mediated transcriptional activity. The high conformational stability in ESR1/melatonin complex could modulate the activity of estrogen receptor-α and probably inhibit cancer cell growth and progression through the regulation of PI3K/AKT and MAPK pathways. Additionally, melatonin interactions with p53, SMAD3, MYC, and STAT3 suggest a broader impact on tumor cell regulation and survival pathways.
Conclusion
These findings provide novel insights into the molecular mechanisms underlying melatonin’s anti-cancer effects on thymoma and related cancer types, offering a potential avenue for targeted therapeutic interventions.
Zitieren
APA
Akbaba, E., & Düzgün, Z. (2026). Network Pharmacology, Molecular Docking and Dynamics-Based Strategy to Explore the Potential Mechanism of Melatonin Against Thymoma. Ahi Evran Medical Journal, 10(1), 120-132. https://doi.org/10.46332/aemj.1666706
Vancouver
Akbaba E, Düzgün Z. Network Pharmacology, Molecular Docking and Dynamics-Based Strategy to Explore the Potential Mechanism of Melatonin Against Thymoma. Ahi Evran Medical Journal. 2026;10(1):120-132. doi:10.46332/aemj.1666706
BibTeX
@article{Akbaba2026,
author = {Akbaba, Emel and Düzgün, Zekeriya},
title = {Network Pharmacology, Molecular Docking and Dynamics-Based Strategy to Explore the Potential Mechanism of Melatonin Against Thymoma},
journal = {Ahi Evran Medical Journal},
year = {2026},
volume = {10},
number = {1},
pages = {120--132},
doi = {10.46332/aemj.1666706}
}
EUVIMED